According to the research report titles ‘Global Hydroxychloroquine Sulfate Tablets Market Size study, by Grade (USP Standards Grade, EP Standards Grade, Pharmaceutical Standard Grade and Others), by Application (Malaria, Arthritis, Skin Lesions, Lupus, COVID 19 and Others) and Regional Forecasts 2020-2026’, available with Market Study Report, global hydroxychloroquine sulfate tablets market is projected to witness tremendous growth during 2020-2026.
 

Rising prevalence of malaria and growing need for safe & efficient medicines are bolstering the demand for hydroxychloroquine sulfate tablets. For instance, in 2018, Africa witnessed 210,000 cases of malaria, providing impetus to market growth. Hydroxychloroquine sulfate tablets are commonly used in malaria treatment due to their strong existence against huge stains of parasites. Other benefits including easy availability, ability to reduce loss of platelets, and affordability are expected to propel the growth of hydroxychloroquine sulfate tablets market during 2020-2026.

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2633135/
 

Various companies are experimenting with different dosages and developing novel ways to decrease the impacts of chronic skin diseases as the substance does not aggravate oil production or acne. Introduction of policies for medication sales and inflowing private investment will have a positive impact on hydroxychloroquine sulfate tablets market. Moreover, as per the Center for Disease Control & Prevention, the in-vitro laboratory studies outside human species-action claims the efficacy of this drug against COVID-19, thereby bolstering the popularity of hydroxychloroquine sulfate tablets.

Based on grade, the market is segmented into USP, pharmaceutical, EP, and other standard grade. With respect to the application spectrum, the industry is divided into malaria, arthritis, lupus, skin lesions, COVID-19, and others.
 

As per regional overview, global hydroxychloroquine sulfate tablets industry is segmented into North America, Asia Pacific, Europe, Latin America and Rest of the World. Asia Pacific market is expected to witness substantial growth over the forecast period, due to the presence of major players in the region. Favorable initiatives by the government is expected to contribute to hydroxychloroquine sulfate tablets market share in APAC.
 

Leading players in global hydroxychloroquine sulfate tablets market include Teva Pharmaceutical Industries Ltd., Zydus Cadila, Ipca Laboratories Ltd., Abbott Laboratories, Novartis AG, Bayer AG, Abcam plc, Rising Pharma Holdings Inc., and Mylan N.V. among others.